INSP Inspire Medical Systems

UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023

UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023

MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023.

Inspire is now scheduled to present at 1:00 p.m. Eastern Time. The presentation will be accessible via a live webcast .

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at .

About Inspire Medical Systems

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit .

Investor and Media Contact

Ezgi Yagci

Vice President, Investor Relations



617-549-2443



EN
03/05/2023

Underlying

INSPInspire Medical Systems

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inspire Medical Systems

 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2...

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibility Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per diluted share of $4.89; adjusted net income per diluted share of $2.42Operating cash flow of $52.5 million in the fourth quarter with full year operating ...

February 11, 2026 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue ...

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance Inspire Announces Appointment of Matt Osberg as Executive Vice President and Chief Financial Officer Joining the Company in the First Quarter of 2026 MINNEAPOLIS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep a...

January 12, 2026 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2...

Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 MINNEAPOLIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and full year 2025 after the close of trading on Wednesday, February 11. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Ins...

January 7, 2026 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morga...

Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible vi...

December 29, 2025 1 EN
 PRESS RELEASE
Free
INSP Inspire Medical...

Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Ann...

Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025. Inspire is scheduled to present at 11:30 a.m. Eastern Time. The presentation will be accessib...

November 18, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch